Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;36(2):2222333.
doi: 10.1080/14767058.2023.2222333.

Clinical chorioamnionitis at term is characterized by changes in the plasma concentration of CHCHD2/MNRR1, a mitochondrial protein

Affiliations

Clinical chorioamnionitis at term is characterized by changes in the plasma concentration of CHCHD2/MNRR1, a mitochondrial protein

Mariachiara Bosco et al. J Matern Fetal Neonatal Med. 2023 Dec.

Abstract

Objective: Mitochondrial dysfunction was observed in acute systemic inflammatory conditions such as sepsis and might be involved in sepsis-induced multi-organ failure. Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 2 (CHCHD2), also known as Mitochondrial Nuclear Retrograde Regulator 1 (MNRR1), a bi-organellar protein located in the mitochondria and the nucleus, is implicated in cell respiration, survival, and response to tissue hypoxia. Recently, the reduction of the cellular CHCHD2/MNRR1 protein, as part of mitochondrial dysfunction, has been shown to play a role in the amplification of inflammatory cytokines in a murine model of lipopolysaccharide-induced systemic inflammation. The aim of this study was to determine whether the plasma concentration of CHCHD2/MNRR1 changed during human normal pregnancy, spontaneous labor at term, and clinical chorioamnionitis at term.

Methods: We conducted a cross-sectional study that included the following groups: 1) non-pregnant women (n = 17); 2) normal pregnant women at various gestational ages from the first trimester until term (n = 110); 3) women at term with spontaneous labor (n = 50); and 4) women with clinical chorioamnionitis at term in labor (n = 25). Plasma concentrations of CHCHD2/MNRR1 were assessed by an enzyme-linked immunosorbent assay.

Results: 1) Pregnant women at term in labor with clinical chorioamnionitis had a significantly higher plasma CHCHD2/MNRR1 concentration than those in labor without chorioamnionitis (p = .003); 2) CHCHD2/MNRR1 is present in the plasma of healthy non-pregnant and normal pregnant women without significant differences in its plasma concentrations between the two groups; 3) there was no correlation between maternal plasma CHCHD2/MNRR1 concentration and gestational age at venipuncture; and 4) plasma CHCHD2/MNRR1 concentration was not significantly different in women at term in spontaneous labor compared to those not in labor.

Conclusions: CHCHD2/MNRR1 is physiologically present in the plasma of healthy non-pregnant and normal pregnant women, and its concentration does not change with gestational age and parturition at term. However, plasma CHCHD2/MNRR1 is elevated in women at term with clinical chorioamnionitis. CHCHD2/MNRR1, a novel bi-organellar protein located in the mitochondria and the nucleus, is released into maternal plasma during systemic inflammation.

Keywords: Bi-organelle protein; infection; intravascular inflammation; labor; mitochondrial dysfunction; pregnancy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Plasma concentration (pg/ml) of CHCHD2/MNRR1 in non-pregnant and normal pregnant women [723 (584-5217) pg/mL vs. 747 (477-4668) pg/mL pg/mL]. Data are reported as the median and as the interquartile range. The y-axis is in logarithmic scale.
Figure 2.
Figure 2.
Plasma CHCHD2/MNRR1 concentration (pg/ml) of pregnant women at term not in labor and those at term in spontaneous labor [1038 (527-9834) pg/mL vs. 819 (515-4773]. Data are reported as the median and as the interquartile range. The y-axis is in logarithmic scale.
Figure 3.
Figure 3.
Plasma CHCHD2/MNRR1 concentration (pg/ml) of pregnant women at term in labor without and with clinical chorioamnionitis [819 (515-4773) pg/mL vs1722 (1201-3757) pg/mL]. Data are reported as the median and as the interquartile range. The y-axis is in logarithmic scale.

References

    1. Rouse DJ, Landon M, Leveno KJ, et al. The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes. Am J Obstet Gynecol. 2004. Jul;191(1):211–6. - PubMed
    1. Alexander JM, McIntire DM, Leveno KJ. Chorioamnionitis and the prognosis for term infants. Obstetrics and gynecology. 1999. Aug;94(2):274–8. - PubMed
    1. Woodd SL, Montoya A, Barreix M, et al. Incidence of maternal peripartum infection: A systematic review and meta-analysis. PLoS Med. 2019. Dec;16(12):e1002984. - PMC - PubMed
    1. Newton ER. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol. 1993. Dec;36(4):795–808. - PubMed
    1. Tita AT, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010. Jun;37(2):339–54. - PMC - PubMed